- Home
- FDMT vs TEI Comparison
FDMT vs TEI Comparison
Compare FDMT & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- TEI
- Stock Information
- Founded
- FDMT 2013
- TEI 1993
- Country
- FDMT United States
- TEI United States
- Employees
- FDMT N/A
- TEI N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- TEI Finance Companies
- Sector
- FDMT Health Care
- TEI Finance
- Exchange
- FDMT Nasdaq
- TEI Nasdaq
- Market Cap
- FDMT 268.6M
- TEI 256.5M
- IPO Year
- FDMT 2020
- TEI N/A
- Fundamental
- Price
- FDMT $4.28
- TEI $5.50
- Analyst Decision
- FDMT Buy
- TEI
- Analyst Count
- FDMT 10
- TEI 0
- Target Price
- FDMT $35.00
- TEI N/A
- AVG Volume (30 Days)
- FDMT 725.7K
- TEI 142.4K
- Earning Date
- FDMT 05-08-2025
- TEI 01-01-0001
- Dividend Yield
- FDMT N/A
- TEI 10.51%
- EPS Growth
- FDMT N/A
- TEI N/A
- EPS
- FDMT N/A
- TEI N/A
- Revenue
- FDMT $37,000.00
- TEI N/A
- Revenue This Year
- FDMT $11,029.73
- TEI N/A
- Revenue Next Year
- FDMT $44.15
- TEI N/A
- P/E Ratio
- FDMT N/A
- TEI N/A
- Revenue Growth
- FDMT N/A
- TEI N/A
- 52 Week Low
- FDMT $3.73
- TEI $4.35
- 52 Week High
- FDMT $36.25
- TEI $5.39
- Technical
- Relative Strength Index (RSI)
- FDMT 43.33
- TEI 64.30
- Support Level
- FDMT $3.73
- TEI $5.35
- Resistance Level
- FDMT $4.40
- TEI $5.47
- Average True Range (ATR)
- FDMT 0.35
- TEI 0.06
- MACD
- FDMT 0.02
- TEI 0.01
- Stochastic Oscillator
- FDMT 48.64
- TEI 97.22
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments and Money Market Funds.